Welcome to the Jaharis podcast on health and intellectual property. Our series explores current topics related to health law & policy and intellectual property. In each episode, our Jaharis Faculty Fellow will interview a leading figure doing cutting-edge work at the intersection of health and IP. Gene editing technologies, precision medicine, 3-D printing, drug price increases, and strategies to fight antibiotic resistance are just a few of the areas in which these two dynamic legal fields increasingly intersect with one another.
Click on the podcast titles below to listen or download the episodes on iTunes.
Introduction
Welcome to the Jaharis Podcast!
Jacob Sherkow from the New York School of Law is our first guest. His recent work focuses on intellectual property and information policy issues surrounding efforts to cure cancer. We discuss patents, the role of public-private partnerships in cancer R&D and the Cancer Moonshot Initiative.
Exploring the Microbiome
Featuring Rachel Sachs from Washington University Law
In this episode we explore the microbiome -- the world of microbes inside your body. Rachel Sachs from the Washington University School of Law in Saint Louis joins us to discuss intellectual property issues surrounding the microbiome, including emerging treatments and therapies that are starting to take advantage of microbiome research.
Fighting Antibiotic Resistance
Featuring Kevin Outterson, Executive Director of CARB-X
More than 23,000 people die every year in the US from antibiotic-resistant bacteria. We welcome to the podcast Kevin Outterson, executive director of CARB-X (Combating Antibiotic Resistance Bacteria Biopharmaceutical Accelerator), a USD 450 million partnership that is taking the lead in protecting humanity from bacterial threats.